Predicting functional outcome after stroke by modelling baseline clinical and CT variables.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 20233732)

Published in Age Ageing on March 15, 2010

Authors

John M Reid1, Gord J Gubitz, Dingwei Dai, David Kydd, Gail Eskes, Yvette Reidy, Christine Christian, Carl E Counsell, Martin Dennis, Stephen J Phillips

Author Affiliations

1: Department of Neurology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK. johnmreid@doctors.net.uk

Articles by these authors

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet (2012) 10.30

Blood pressure and clinical outcomes in the International Stroke Trial. Stroke (2002) 3.94

Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet (2005) 3.56

Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis. BMJ (2003) 3.31

Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke (2002) 2.83

Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ (2008) 2.43

Stroke. Lancet (2003) 2.40

Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study. Lancet Neurol (2008) 2.39

Do acute phase markers explain body temperature and brain temperature after ischemic stroke? Neurology (2012) 2.03

Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol (2009) 1.98

Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke (2004) 1.91

Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol (2012) 1.79

Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials (2008) 1.79

Diffusion-weighted imaging and diagnosis of transient ischemic attack. Ann Neurol (2014) 1.72

Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med (2009) 1.63

Variation in pregnancy outcomes following statewide implementation of a prenatal home visitation program. Arch Pediatr Adolesc Med (2010) 1.62

Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol (2013) 1.62

Seizure risk with AVM treatment or conservative management: prospective, population-based study. Neurology (2012) 1.56

Dual effects of body-weight supported treadmill training on cardiovascular fitness and walking ability early after stroke: a randomized controlled trial. Neurorehabil Neural Repair (2013) 1.55

Evaluating an organized palliative care approach in patients with severe stroke. Can J Neurol Sci (2009) 1.54

Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis (2011) 1.53

Effects of introducing an integrated care pathway in an acute stroke unit. Age Ageing (2004) 1.52

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials (2011) 1.49

Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial. Stroke (2007) 1.44

Patterns of medication exposures in hospitalized pediatric patients with acute renal failure requiring intermittent or continuous hemodialysis. Pediatr Crit Care Med (2013) 1.42

Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database. Pediatr Crit Care Med (2015) 1.41

Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network. Stroke (2004) 1.41

Blood culture contamination rates after skin antisepsis with chlorhexidine gluconate versus povidone-iodine in a pediatric emergency department. Infect Control Hosp Epidemiol (2010) 1.41

Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med (2012) 1.38

Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr (2014) 1.26

Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition. Cancer Res (2006) 1.25

Fatigue associated with stroke and other neurologic conditions: Implications for stroke rehabilitation. Arch Phys Med Rehabil (2003) 1.23

Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res (2003) 1.21

The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke (2011) 1.19

Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke (2008) 1.15

Predictors of adherence to secondary preventive medication in stroke patients. Ann Behav Med (2011) 1.13

Developing a measure of sluggish cognitive tempo for children: content validity, factor structure, and reliability. Psychol Assess (2009) 1.09

Improving adherence to medication in stroke survivors: a pilot randomised controlled trial. Ann Behav Med (2013) 1.09

Cognitive-motor interference during functional mobility after stroke: state of the science and implications for future research. Arch Phys Med Rehabil (2013) 1.09

Prevalence of polypharmacy exposure among hospitalized children in the United States. Arch Pediatr Adolesc Med (2011) 1.07

Stroke liaison workers for stroke patients and carers: an individual patient data meta-analysis. Cochrane Database Syst Rev (2010) 1.06

Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol (2010) 1.06

Interventions for post-stroke fatigue. Cochrane Database Syst Rev (2009) 1.04

Mortality in Parkinson's disease: a systematic review and meta-analysis. Mov Disord (2014) 1.04

Impact of disability status on ischemic stroke costs in Canada in the first year. Can J Neurol Sci (2012) 1.01

Variations in quality indicators of acute stroke care in 6 European countries: the European Implementation Score (EIS) Collaboration. Stroke (2011) 1.01

Door-to-needle time and the proportion of patients receiving intravenous thrombolysis in acute ischemic stroke: uniform interpretation and reporting. Stroke (2013) 1.01

Associations of clinical stroke misclassification ('clinical-imaging dissociation') in acute ischemic stroke. Cerebrovasc Dis (2010) 0.99

Dehydration in hospital-admitted stroke patients: detection, frequency, and association. Stroke (2011) 0.99

The presentation and clinical course of intracranial developmental venous anomalies in adults: a systematic review and prospective, population-based study. Stroke (2009) 0.96

The role of indigenous microflora in the development of murine intestinal fucosyl- and sialyltransferases. FASEB J (2002) 0.94

Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial. BMC Neurol (2010) 0.94

Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results. Mov Disord (2006) 0.94

The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease. J Neurol (2011) 0.93

Regulation of intestinal ontogeny: effect of glucocorticoids and luminal microbes on galactosyltransferase and trehalase induction in mice. Glycobiology (2004) 0.93

Dysphagia in acute stroke: a long-awaited trial. Lancet Neurol (2006) 0.92

Electrophysiological assessment of language function following stroke. Clin Neurophysiol (2003) 0.90

Neuropsychological functioning following craniopharyngioma removal. J Clin Exp Neuropsychol (2008) 0.89

Patterns of brain arteriovenous malformation treatment: prospective, population-based study. Stroke (2008) 0.89

Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study. Stroke (2010) 0.88

Improving adherence to medication in stroke survivors (IAMSS): a randomised controlled trial: study protocol. BMC Neurol (2010) 0.88

Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev (2010) 0.88

Interventions for post-stroke fatigue. Cochrane Database Syst Rev (2015) 0.87

Renal dysfunction in stroke patients: a hospital-based cohort study and systematic review. Int J Stroke (2014) 0.86

A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city. J Neurol Neurosurg Psychiatry (2012) 0.86

Association of hospital and provider types on sickle cell disease outcomes. Pediatrics (2013) 0.86

Patient volume and quality of care for young children hospitalized with acute gastroenteritis. Arch Pediatr Adolesc Med (2011) 0.85

Clinical and imaging services for TIA and minor stroke: results of two surveys of practice across the UK. BMJ Open (2013) 0.85

Timed tests of motor function in Parkinson's disease. Parkinsonism Relat Disord (2010) 0.85

Giant trichophytobezoar in a pediatric patient with trichotillomania. Pediatr Radiol (2002) 0.84

A systematic review of biomarkers for disease progression in Parkinson's disease. BMC Neurol (2013) 0.84

Fatigue impact scale demonstrates greater fatigue in younger stroke survivors. Can J Neurol Sci (2012) 0.84

Predictors of antiemetic alteration in pediatric acute myeloid leukemia. Pediatr Blood Cancer (2014) 0.84

A systematic review of perceived barriers and motivators to physical activity after stroke. Int J Stroke (2012) 0.84

Shape analysis of 123I-N-omega-fluoropropyl-2-beta-carbomethoxy-3beta-(4-iodophenyl) nortropane single-photon emission computed tomography images in the assessment of patients with parkinsonian syndromes. Nucl Med Commun (2009) 0.81

The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2. Stroke (2013) 0.81

Predictions models in acute stroke: potential uses and limitations. Stroke (2008) 0.81

Nasogastric feeding for stroke patients: practice and education. Br J Nurs (2015) 0.81

Long-term visibility of primary intracerebral hemorrhage on magnetic resonance imaging. J Stroke Cerebrovasc Dis (2007) 0.81

Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months. Int J Geriatr Psychiatry (2008) 0.81

Non-completion of changes to prescribed medications in people with Parkinson's disease. Age Ageing (2007) 0.81

Predicting patient-reported stroke outcomes: a validation of the six simple variable prognostic model. Cerebrovasc Dis Extra (2013) 0.80

Changes in arterial oxygen saturation before and after enteral feeding tube insertion in dysphagic stroke patients. Age Ageing (2004) 0.79

A feasibility study to investigate the clinical application of functional electrical stimulation (FES), for dropped foot, during the sub-acute phase of stroke - A randomized controlled trial. Physiother Theory Pract (2012) 0.79

Powered wheelchair skills training for persons with stroke: a randomized controlled trial. Am J Phys Med Rehabil (2014) 0.79

A pilot study to assess if urine specific gravity and urine colour charts are useful indicators of dehydration in acute stroke patients. J Adv Nurs (2011) 0.79

Prevention of venous thromboembolism after acute ischaemic stroke. Lancet (2007) 0.79

Limb activation effects in hemispatial neglect. Arch Phys Med Rehabil (2003) 0.78

Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts. Stroke (2009) 0.78

Developing predictive models of excellent and devastating outcome after stroke. Age Ageing (2012) 0.78

British Association of Stroke Physicians: benchmarking survey of stroke services. Age Ageing (2003) 0.78

Variation in surgical outcomes for adolescents and young adults with inflammatory bowel disease. Pediatrics (2013) 0.78

"My doctor has changed my pills without telling me": impact of generic medication switches in stroke survivors. J Behav Med (2013) 0.78